BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17355217)

  • 1. Emerging drugs in neuropathic pain.
    Gilron I; Coderre TJ
    Expert Opin Emerg Drugs; 2007 Mar; 12(1):113-26. PubMed ID: 17355217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for neuropathic pain.
    Gilron I; Dickenson AH
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):329-41. PubMed ID: 24793304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacotherapy of chronic neuropathic pain].
    Otto J; Forstenpointner J; Binder A; Baron R
    Internist (Berl); 2019 Jul; 60(7):711-723. PubMed ID: 31187164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology and treatment of neuropathic pains.
    Jensen TS; Madsen CS; Finnerup NB
    Curr Opin Neurol; 2009 Oct; 22(5):467-74. PubMed ID: 19741531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatments for neuropathic pain.
    Rice AS; Hill RG
    Annu Rev Med; 2006; 57():535-51. PubMed ID: 16409165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.
    Sawynok J
    Eur J Pain; 2014 Apr; 18(4):465-81. PubMed ID: 24108446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids for the treatment of neuropathic pain: clinical evidence.
    Ashton JC; Milligan ED
    Curr Opin Investig Drugs; 2008 Jan; 9(1):65-75. PubMed ID: 18183533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New directions in pain management.
    MacPherson RD
    Drugs Today (Barc); 2002 Feb; 38(2):135-45. PubMed ID: 12532190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging trends in the pharmacotherapy of chronic pain.
    Nitu AN; Wallihan R; Skljarevski V; Ramadan NM
    Expert Opin Investig Drugs; 2003 Apr; 12(4):545-59. PubMed ID: 12665411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.
    Papanas N; Ziegler D
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):393-407. PubMed ID: 27813425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic treatment of neuropathic pain.
    Attal N
    Acta Neurol Belg; 2001 Mar; 101(1):53-64. PubMed ID: 11379277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in neuropathic pain treatments with special reference to fibromyalgia.
    Offenbaecher M; Ackenheil M
    CNS Spectr; 2005 Apr; 10(4):285-97. PubMed ID: 15902759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in pharmacotherapy of pain management.
    Davis MP; Walsh D; Lagman R; LeGrand SB
    Lancet Oncol; 2005 Sep; 6(9):696-704. PubMed ID: 16129370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
    Leung A; Wallace MS; Ridgeway B; Yaksh T
    Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug management of cancer-related peripheral neuropathic pain: A systematic review of the literature].
    Medioni J; Pickering G; Delorme C; Lansaman T; Lanteri-Minet M; Legras A; Navez M; Prudhomme M; Serrie A; Viel É; Perrot S
    Bull Cancer; 2019 Sep; 106(9):784-795. PubMed ID: 31202559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology and Pharmacology of Neuropathic Pain.
    Alles SRA; Smith PA
    Pharmacol Rev; 2018 Apr; 70(2):315-347. PubMed ID: 29500312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathic agents and pain. New strategies.
    Chong MS; Brandner B
    Biomed Pharmacother; 2006 Aug; 60(7):318-22. PubMed ID: 16842964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should cannabinoids be used as analgesics for neuropathic pain?
    Rice AS
    Nat Clin Pract Neurol; 2008 Dec; 4(12):654-5. PubMed ID: 19015657
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous).
    Attal N; Mazaltarine G; Perrouin-Verbe B; Albert T;
    Ann Phys Rehabil Med; 2009 Mar; 52(2):124-41. PubMed ID: 19909703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society.
    Moulin DE; Clark AJ; Gilron I; Ware MA; Watson CP; Sessle BJ; Coderre T; Morley-Forster PK; Stinson J; Boulanger A; Peng P; Finley GA; Taenzer P; Squire P; Dion D; Cholkan A; Gilani A; Gordon A; Henry J; Jovey R; Lynch M; Mailis-Gagnon A; Panju A; Rollman GB; Velly A;
    Pain Res Manag; 2007; 12(1):13-21. PubMed ID: 17372630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.